After Yet Another Failure, Stem Cell Leaders Double Down

–Could repeated doses of stem cells turn the tide of negative trials? Despite an unrelieved history of negative trials, stem cell leaders continue to defend their field. In response to the failure of yet another cardiac stem clinical trial, Roberto Bolli, a prominent leader in the field, argued that it’s time for a “paradigm shift” in...Click here to continue reading...

Source: CardioBrief - February 21, 2017 Category: Cardiology Authors: Larry Husten Tags: Interventional Cardiology & Surgery People, Places & Events Policy & Ethics searching for the pony Stem cell stem cell therapy Source Type: blogs